Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01768377Phase 3Unknown
Phase 3, randomised trial of Lidocaine Hydrochloride Injection, without epinephrine, sponsored by Tehran University of Medical Sciences. Primary endpoint: Time required for intubation at 1 month. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01768377.